Telix Pharmaceuticals | TLX - Pre Tax Profit


Telix Pharmaceuticals reported AUD76.73M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Cochlear AUD 121.1M 155.6M Jun/2025
CSL USD 2.61B 1.21B Dec/2025
Integral Diagnostics AUD 14.49M 47.37M Jun/2024
Mayne Pharma AUD -14.7M 42.91M Dec/2024
Medical Developments International AUD -149K 466K Jun/2025
Mesoblast USD 39.72M 93.81M Dec/2025
Neuren Pharmaceuticals AUD 19.21M 9.35M Dec/2025
Pacific Edge NZD -714K 49K Mar/2024
Polynovo AUD 1.96M 146K Dec/2025
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Ramsay Health Care AUD 240.5M 136.75M Dec/2025
ResMed USD 502.31M 6.16M Mar/2026
Sonic Healthcare AUD 402.01M 53.16M Jun/2025